secwatch.observer — SEC 8-K summary
======================================

Issuer:     electroCore, Inc. (ECOR)
CIK:        0001560258
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0001641172-25-008177
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

electroCore completes acquisition of NeuroMetrix; $4.49/share plus CVRs
-----------------------------------------------------------------------

- Cash consideration of $4.49 per NURO share; each share also gets one CVR tied to Quell sales milestones.
- CVR payments include 8% of Quell Net Sales up to $500K in first year, 6% in second year, plus DPNCheck proceeds.
- electroCore gains Quell Fibromyalgia Solution, expects to leverage VA Hospital System distribution channel.
- NURO shares to be de-listed from Nasdaq Capital Market before trading on May 2, 2025.
- Transaction approved by NURO stockholders on March 21, 2025; closed May 1, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560258/000164117225008177/0001641172-25-008177-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560258/000164117225008177/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008177

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer